tm logo

Monitor this mark

View On USPTO

ONTELRIQ
Dead/Cancelled
IR CANCELLED; US REGISTRATION CANCELLED

on 29 Apr 2023

Last Applicant/ Owned by

IPSEN PHARMA S.A.S

F-92100 BOULOGNE BILLANCOURT

FR

Serial Number

79129963 filed on 29th Apr 2013

Registration Number

4473154 registered on 28th Jan 2014

in the Principal Register

Correspondent Address

William S. Frommer, Esq.

William S. Frommer, Esq.

745 Fifth Avenue, 10th Floor

NEW YORK NY 10151

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ONTELRIQ

Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, uroloty and for cardivascular and cognitive disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, uroloty and for cardivascular and cognitive disorders

Mark Details

Serial Number

No 79129963

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
20th Nov 2023DEATH OF INTERNATIONAL REGISTRATION
20th Nov 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
20th Mar 2022TOTAL INVALIDATION PROCESSED BY THE IB
17th Feb 2022INVALIDATION PROCESSED
17th Feb 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
26th Oct 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26th Feb 2021CANCELLED SECTION 71
19th May 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
13th May 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Mar 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED